NCT03570957View on ClinicalTrials.gov

A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 17, 2018

Primary Completion Date

December 27, 2018

Study Completion Date

December 27, 2018

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

MT-2990

MT-2990 solution for injection in vial

DRUG

Placebo

Placebo solution for injection in vial

Trial Locations (1)

Unknown

Investigational Site, Tokyo

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY